Heidrun S.
- Country
- Germany
- Department
- Klinik für Hämatologie, Onkologie und Palliativmedizin
Research Overview
Data & Insights
Has run more than one trial at 0 of 14 partner sites.
Specializations
Lung Cancer Specialization
The investigator focuses on treating advanced forms of large-cell neuroendocrine carcinoma of the lung, particularly addressing cases where curative treatment is not feasible. Their expertise extends to managing both locally advanced and metastatic disease states.
- Advanced LCNEC Management
- Metastatic Lung Cancer
- Neuroendocrine Tumors
Immunotherapy Applications
Their therapeutic approach includes the integration of immunotherapy treatments, specifically exploring the role of immune checkpoint inhibitors in combination with traditional chemotherapy protocols for lung cancer treatment.
- Combined Modality Treatment
- Immune System Therapy
- Advanced Treatment Protocols
Treatment Innovation
The investigator specializes in developing enhanced therapeutic strategies for thoracic oncology, with particular emphasis on combining standard chemotherapy approaches with newer targeted treatments to improve patient survival outcomes.
- Survival Outcome Assessment
- Therapeutic Innovation
- Treatment Protocol Development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.